Scorpion Therapeutics, Inc.
https://www.scorpiontx.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Scorpion Therapeutics, Inc.
Pierre Fabre Pushes To Be Partner Of Choice For Budding Biotechs
Francesco Hofmann, head of R&D at the mid-sized French group, tells Scrip that its strategy of not playing in the spaces that are dominated by big pharma is paying off.
Scorpion Sinks Pincers Into Funding Round For PI3K Inhibitor
The oncology-focused start-up announced it closed a $150m series C financing that it plans to use to advance STX-478.
Vision And Resilience, The Hallmarks Of Axel Hoos’ Leadership Approach
Axel Hoos helped create the field of immuno-oncology and now has his sights on proving the worth of Scorpion Therapeutics’ precision oncology platform. The executive spoke with In Vivo about company culture, the Scorpion strategy and resilience in the face of resistance.
Pierre Fabre Continues Oncology R&D Push
The French firm has followed up its recent acquisition of Swiss lung cancer specialist Vertical Bio by signing a pact with Vernalis.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice